Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

Delayed Data
As of Oct 02
 +2.84 / +3.09%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 113.00, with a high estimate of 134.00 and a low estimate of 92.00. The median estimate represents a +19.14% increase from the last price of 94.85.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.10%
Growthannually -76.44%


Growthquarterly --
Growthannually -100.00%
Key to the earnings and sales forecast charts.